EUVIMEDEUVIMED entdecken
Crossref

Echinacoside promotes osteogenesis and angiogenesis and inhibits osteoclast formation

Qingqing Yi iD, Miaomiao Sun, Guowei Jiang, Pengchen Liang, Qing Chang, Rong Yang

European Journal of Clinical Investigation · 2024-08 · 54 (8)

DOI: 10.1111/eci.14198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 19.03.2024. Verfasst von Qingqing Yi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Osteogenesis, Osteoclasts, Neovascularization, Physiologic, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Shanghai Key Specialty of Clinical Pharmacy, The Nature Science Foundation of Jiading District, Shanghai, Key Projects of Jiading District Health Commission, Shanghai (No.2020-ZD-03).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this research is to demonstrate echinacoside promotes osteogenesis and angiogenesis and inhibits osteoclast formation.

Methods

We conducted a cell experiment in vitro to study how echinacoside affects angiogenesis, osteogenesis and osteoclast formation. We used polymerase chain reaction and Western blotting to detect the expression levels of proteins and genes related to angiogenesis, osteogenesis and osteoclast formation. We established a bone fracture model with rats to test angiogenesis, osteogenesis and osteoclast formation of echinacoside. We labelled osteogenic markers, blood vessels and osteoclastic markers in fracture sections of rats.

Results

The in vitro cell experiments showed echinacoside improved the osteogenic activity of mouse embryo osteoblast precursor cells and promoted the migration and tube formation of human umbilical vein endothelial cells. In addition, it inhibited differentiation of mouse leukaemia cells of monocyte macrophage. Echinacoside increased the expression of related proteins and genes and improved angiogenesis and osteogenesis while inhibiting osteoclast formation by repressing the expression of related proteins and genes. From in vivo experiments, the results of IHC and HE experiments demonstrated echinacoside significantly decreased the content of MMP‐9 and improved the content of VEGF and OCN. The fluorescence immunoassay showed echinacoside promoted the activities of RUNX2 and VEGF and inhibited CTSK. Echinacoside reduced the content of TNF‐α, IL‐1β and IL‐6, thus demonstrating its anti‐inflammatory activity.

Conclusion

Echinacoside improved angiogenesis and osteogenesis and inhibited osteoclast formation to promote fracture healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisOsteoclastsNeovascularization, PhysiologicHuman Umbilical Vein Endothelial CellsGlycosidesMatrix Metalloproteinase 9AnimalsMiceHumansRatsVascular Endothelial Growth Factor AMaleCell DifferentiationOsteoblastsRats, Sprague-DawleyCell MovementOsteocalcinCore Binding Factor Alpha 1 SubunitAngiogenesis

Stichwörter der Autor:innen

angiogenesisechinacosidefracture healingosteoclastic reductionosteogenesis

Substanzen

echinacosideGlycosidesMatrix Metalloproteinase 9Vascular Endothelial Growth Factor AOsteocalcinCore Binding Factor Alpha 1 Subunit

Autor:innen und Institutionen

  • Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
  • Luoxi (Shanghai) Medical Technology Co LTD, Shanghai, China.
  • Pharmacy Department, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
  • School of Microelectronics, Shanghai University, Shanghai, China.
  • Institute of Digestive Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Pathology Department, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.

ORCID-Profile: Qingqing Yi

Förderung

  • Shanghai Key Specialty of Clinical Pharmacy
  • The Nature Science Foundation of Jiading District, Shanghai
  • Key Projects of Jiading District Health Commission, Shanghai (No.2020-ZD-03)

Zitieren

APA

Yi, Q., Sun, M., Jiang, G., Liang, P., Chang, Q., & Yang, R. (2024). Echinacoside promotes osteogenesis and angiogenesis and inhibits osteoclast formation. European Journal of Clinical Investigation, 54(8). https://doi.org/10.1111/eci.14198

Vancouver

Yi Q, Sun M, Jiang G, Liang P, Chang Q, Yang R. Echinacoside promotes osteogenesis and angiogenesis and inhibits osteoclast formation. European Journal of Clinical Investigation. 2024;54(8). doi:10.1111/eci.14198

BibTeX
@article{Yi2024,
  author = {Yi, Qingqing and Sun, Miaomiao and Jiang, Guowei and Liang, Pengchen and Chang, Qing and Yang, Rong},
  title = {Echinacoside promotes osteogenesis and angiogenesis and inhibits osteoclast formation},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  volume = {54},
  number = {8},
  doi = {10.1111/eci.14198}
}
Kostenlos starten →